MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$7.39 USD
+0.13 (1.79%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $7.38 -0.01 (-0.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for MiMedx Group, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 321 | 268 | 259 | 248 | 299 |
Cost Of Goods | 55 | 48 | 43 | 39 | 43 |
Gross Profit | 267 | 220 | 215 | 209 | 256 |
Selling & Adminstrative & Depr. & Amort Expenses | 230 | 245 | 220 | 254 | 277 |
Income After Depreciation & Amortization | 37 | -25 | -5 | -45 | -21 |
Non-Operating Income | 0 | 0 | 0 | -16 | -4 |
Interest Expense | 6 | 5 | 5 | 0 | 0 |
Pretax Income | 31 | -30 | -10 | -62 | -26 |
Income Taxes | -37 | 0 | 0 | -12 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 67 | -30 | -10 | -49 | -26 |
Extras & Discontinued Operations | -9 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 58 | -30 | -10 | -49 | -26 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 41 | -20 | 1 | -36 | -12 |
Depreciation & Amortization (Cash Flow) | 4 | 5 | 6 | 9 | 9 |
Income After Depreciation & Amortization | 37 | -25 | -5 | -45 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 145.96 | 112.91 | 110.35 | 108.26 | NA |
Diluted EPS Before Non-Recurring Items | 0.10 | -0.33 | -0.15 | -0.77 | NA |
Diluted Net EPS (GAAP) | 0.37 | -0.33 | -0.15 | -0.77 | -0.24 |
Fiscal Year end for MiMedx Group, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 84.71 | 86.83 | 81.71 | 81.26 | 71.68 |
Cost Of Goods | 12.99 | 13.84 | 14.79 | 13.58 | 12.42 |
Gross Profit | 71.72 | 72.99 | 66.92 | 67.67 | 59.26 |
SG&A, R&D, and Dept/Amort Expenses | 58.52 | 49.56 | 56.11 | 64.89 | 62.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 13.20 | 23.43 | 10.81 | 2.78 | -3.38 |
Non-Operating Income | -0.10 | 0.02 | -0.01 | -0.03 | 0.00 |
Interest Expense | 1.69 | 1.59 | 1.68 | 1.63 | 1.55 |
Pretax Income | 11.41 | 25.31 | 9.13 | 1.13 | -4.93 |
Income Taxes | 2.35 | -37.37 | 0.59 | -0.07 | 0.05 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 9.06 | 62.69 | 8.53 | 1.20 | -4.98 |
Extras & Discontinued Operations | 0.20 | 2.19 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 9.26 | 53.48 | 8.53 | 1.20 | -4.98 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 150.03 | 148.08 | 119.33 | 115.87 | 114.40 |
Diluted EPS Before Non-Recurring Items | 0.07 | 0.04 | 0.05 | 0.00 | -0.06 |
Diluted Net EPS (GAAP) | 0.06 | 0.37 | 0.06 | 0.00 | -0.06 |